|
|
Post by rak5555 on Jun 27, 2014 16:14:06 GMT -5
|
|
|
|
Post by 4Balance on Jun 27, 2014 16:18:09 GMT -5
"The most common adverse reactions associated with AFREZZA (2% or greater incidence) are hypoglycemia..."
Since we're promoting Afrezza as a mechanism for reducing hypo attacks, this concerns me. I wonder how this caveat compares to the rapid-acting insulins on the market...??
|
|
|
|
Post by liane on Jun 27, 2014 16:23:15 GMT -5
Any insulin can cause hypoglycemia. This is nothing to worry about on the label. Sort of like sleeping medications "can cause drowsiness".
|
|
|
|
Post by leepoffaith on Jun 27, 2014 16:26:38 GMT -5
My personal opinion on this is when you are administering any type of insulin you are going to have hypoglycemic episodes no matter what. 2% seems pretty low as I remember reading that injectable insulin was around 6%, but that was a few months ago. I believe that the FDA mentions administering Afrezza 20 minutes into your meal and that will help reduce hypoglycemic episodes.
|
|
|
|
Post by 4Balance on Jun 27, 2014 16:28:52 GMT -5
The comment was "2% or greater."
I appreciate the observations that add info on the rapid-acting insulins currently marketed.
|
|
|
|
Post by jpg on Jun 27, 2014 16:36:01 GMT -5
18 pages more to read but this looks really really good!
JPG
|
|
|
|
Post by slushy on Jun 27, 2014 19:14:58 GMT -5
Just to verify, we got approval for both T1 and T2 right?
|
|
|
|
Post by seanismorris on Jun 27, 2014 19:20:34 GMT -5
|
|
|
|
Post by liane on Jun 27, 2014 19:24:58 GMT -5
Just to verify, we got approval for both T1 and T2 right? Yes - From the label: --------------------- INDICATIONS AND USAGE ------------------------- • AFREZZA ® is a rapid acting inhaled insulin indicated to improve glycemic control in adult patients with diabetes mellitus. Important limitations of use: • In patients with type 1 diabetes, must use with a long-acting insulin. |
|
|
|
Post by slushy on Jun 27, 2014 19:39:26 GMT -5
Hey Liane, that's what I assumed, but since it doesn't outright say "for use in type 1 and type 2 diabetes", I wanted to make sure. The only mention of Type 2 I could find was in the notes regarding the trials.
|
|
|
|
Post by liane on Jun 27, 2014 19:43:15 GMT -5
It is strange that they did not explicitly state T1 and T2.
|
|
|
|
Post by lynn on Jun 27, 2014 20:23:35 GMT -5
& it's also strange that it's not referred to for what it is , which is the First ULTRA fast acting insulin EVER!! ( aside from it being inhaled ) .With social media I am confident that the word will spread rapidly as to how BIG this really is for Diabetics ! Word of mouth / social media will help spread the true facts like wildfire !  just wait & see I don't buy anything based on TV ads ( in fact I DVR everything to avoid commercials ) , I buy based on what I hear from real people , this will be no different , patients will be asking for this & with our help spreading the word ( I've already shared the news on Facebook) & I'm quite certain Afrezzauser will be all over this as well He had a nice post on Yahoo today in case you didn't catch it .. , anyways , I am so excited that I'm all over the place ./ but I think I've stated before that I tell EVERYONE about Mannkind / Afrezza, I have yet to meet one person who has heard of it ! In my opinion , this is still ground floor , tho I'm glad I got in at $5 , I want more !! Cheers |
|
|
|
Post by babaoriley on Jun 27, 2014 21:18:35 GMT -5
Hey, Lynn, you are on fire this Friday evening! We should all be very pleased with this afternoon's events. Monday will be a very interesting day. And will likely present opportunities. I think this weekend everyone should come up with strategies that suit their risk tolerance and investment goals. Up, down or sideways, in the next few sessions, let's all be ready to act, if action is what you decide is called for.
|
|
|
|
Post by chmith27 on Jun 27, 2014 22:18:03 GMT -5
in the meantime, can we decide on a new sign off truism for spiro? "it ain't prescribed 'til it's prescribed"... or "we ain't partnered up til we're partnered up"...
|
|
|
|
Post by babaoriley on Jun 27, 2014 22:55:44 GMT -5
LOL, Doc, but I think he'd prefer, "it's all about Technosphere, no matter what Chad says." The gentleman from Florida is a Leona Bay Backer! I can't argue with that hard-headed Greek! Barring a miracle, the short interest will go down in flames. And Spiro dislikes shorts as much as Al Mann does.
We need to provide for a mock funeral for the "unknown short" when we head to Vegas!
|
|
just wait & see 
